1 / 9

Manufacturer and Charity Patient Assistance Programs

Manufacturer and Charity Patient Assistance Programs Presentation to the PAP Task Force September 13, 2006 John Gould Overview Disclaimer Patient Assistance Programs (PAPs) Anti-kickback statute TrOOP Manufacturer PAPs Charity PAPs Access Issues Disclaimer

adamdaniel
Télécharger la présentation

Manufacturer and Charity Patient Assistance Programs

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Manufacturer and Charity Patient Assistance Programs Presentation to the PAP Task Force September 13, 2006 John Gould

  2. Overview • Disclaimer • Patient Assistance Programs (PAPs) • Anti-kickback statute • TrOOP • Manufacturer PAPs • Charity PAPs • Access Issues

  3. Disclaimer • The views expressed are my own, not Arnold & Porter’s or our clients. • Arnold & Porter has represented the pharmaceutical industry in interactions with the HHS Office of Inspector General regarding PAP (and other) issues.

  4. Patient Assistance Programs • Assistance to finically and medically needy • Sponsored by • Manufacturers • Independent charities • States (SPAPs) • Cash subsidies, free or reduced priced drugs • Direct assistance to patients, replenish drugs provided by pharmacies / providers

  5. Anti-kickback Statute • Criminal offense to, knowingly and willfully, offer or pay remuneration to induce or reward the referral or generation of business reimbursable by any Federal health care program - - 42 U.S.C. 1320a-7b

  6. TrOOP • Beneficiary’s level of Part D benefits depends upon True Out-Of-Pocket (TrOOP) costs • Deductible, initial coverage period, doughnut hole, catastrophic coverage • CMS: assistance received from any source other than group health plans, insurers, and government-funded health care programs and similar third-party arrangements will count towards TrOOP

  7. Manufacturer PAPs • Allowed: Operating “outside of Part D” • Part D plans do not pay for PAP-covered drug • Assistance does not count towards TrOOP • Assistance for whole coverage year • Not allowed: • Cost-sharing subsidies • Assistance only during the doughnut hole “pose[s] a heightened risk of abuse” • Coalition model

  8. Independent Charity PAPs • Cost sharing and premium assistance are allowed • Often disease-state based • TrOOP • Independent • Not subject to manufacturer control • Limited information shared with manufacturer regarding assistance • Don’t influence selection of providers or drugs • Bulk donation model

  9. Ongoing Access Issues • Those who are low income but • Not dual eligibles and • Do not qualify for Medicare low income subsidies • Limits on charity PAPs • Lack of funding • Lack of assistance for all disease states • Limits on manufacturer PAPs • Not offered for all drugs • Some limited to patients with no insurance • Filling the doughnut hole not permitted

More Related